Últimas noticias sobre Agape ATP (NASDAQ:ATPC) Bolsa

Agape ATP

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Descubre las acciones que lideran el premercado con sorprendentes subidas y caídas. INNOVATE y más protagonistas hoy.

Las acciones de INNOVATE (VATE) cotizan un 19% más alto; 20 acciones que se mueven en el premercado de EE.UU.

AEHR

ATCH

AVGR

CANG

CHCI

HCWC

LIDR

NMHI

PHIO

PIII

RGNX

RIME

SANG

STAF

URGN

YOSH

Las acciones de KB Home suben 9,1% tras superar expectativas de ganancias. Descubre los mayores ganadores y perdedores del mercado hoy.

Las acciones de KB Home se disparan un 9%; 20 acciones que se mueven en el premercado de EE.UU.

ARQT

BDTX

DRCT

GCTK

ITCI

LAES

LDTC

QBTS

QMMM

RGTI

SAGE

STAI

TRAW

VMAR

Sage Therapeutics sube 34% tras oferta de Biogen. Conoce los mayores ganadores y perdedores del premercado de EE.UU.

Las acciones de Sage Therapeutics (SAGE) se disparan un 34%; 20 acciones que se mueven en premercado

Agape ATP Corp

WIIM

IRBT

iRobot shares are trading lower after the company disclosed substantial doubt about its ability to continue as a going concern.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Geron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) from Neutral to Neutral.

Reiteration

Analyst Ratings

GERN

HC Wainwright & Co. Reiterates Neutral on Geronto Neutral

Heinz Launched Dip For Potato Chips, Same Unmistakable Ketchup, New Way To Enjoy

SFIX

Stitch Fix shares are trading higher following strong Q2 earnings and upbeat Q3 guidance.

GRPN

Groupon shares are trading higher after the company reported better-than-expected Q4 revenue results.

Needham analyst Ryan Koontz maintains Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Buy and lowers the price target from $95 to $90.

Price Target

CIEN

Needham Maintains Buy on Ciena, Lowers Price Target to $90

Rosenblatt analyst Blair Abernethy upgrades Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) from Neutral to Buy and announces $77 price target.

Upgrades

RBRK

Rosenblatt Upgrades Rubrik to Buy, Announces $77 Price Target

TSLA

Tesla shares are trading higher after CEO Elon Musk on social media announced plans to double US vehicle production within two years.

Whitestone REIT Announced That It Has Signed A Lease With The Picklr To Open A 20,909-square-foot Location At Terravita Marketplace In Scottsdale, Arizona

STEC

Santech Holdings Regains NASDAQ Compliance, Closes Chapter On Minimum Bid Price Violation

TLRY

Tilray Beverages Announced The Distribution Expansion For Runner's High Brewing, Its Non-alcoholic Craft Beer Brand, Across 4,500 New Distribution Points

INTC: 9% &#x7C; <a href="https://www.benzinga.com//node/44271204">TSMC Proposes Joint Venture With Nvidia, AMD And Broadcom To Operate Intel's Factories: Report</a>
&nbsp;
GRPN: 27% &#x7C; <a href="https://www.benzinga.com//node/44262868">Groupon shares are trading higher after the company reported better-than-expected Q4 revenue results.</a>
&nbsp;
SFIX: 24% &#x7C; <a href="https://www.benzinga.com//node/44262293">Stitch Fix shares are trading higher following strong Q2 earnings and upbeat Q3 guidance.</a>

INTC

Market-Moving News for March 12th

Intel shares are trading higher following a report suggesting TSMC pitched a joint venture to Nvidia, AMD, Broadcom and Qualcomm to operate Intel's factories.

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) with a Buy and maintains $100 price target.

IMCR

HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

Q1 2025 Guidance
Given the prevailing uncertainty in NIH funding and academic research purchasing, along with normal seasonality, the Company expects Q1 2025 revenues of $19 million to $21 million and gross margin in the 56% to 58% range.

Guidance

HBIO

Harvard Bioscience Expects Q1 Revenue Of $19M-$21M Vs $22.95M Est

Piper Sandler analyst Derek Podhaizer assumes Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) with a Overweight rating and announces Price Target of $22.

Initiation

AESI

Piper Sandler Assumes Atlas Energy Solutions at Overweight, Announces Price Target of $22

HC Wainwright &amp; Co. analyst Sean Lee maintains Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) with a Buy and raises the price target from $7.5 to $9.5.

HC Wainwright & Co. Maintains Buy on Myomo, Raises Price Target to $9.5

TRNR

Interactive Strength Inc.  Secures $3.6M in 3-Year Notes From Institutional Investor, Following $2.9M Investment

Earnings

VNET

VNET Q4 EPADS $(0.01) Misses $0.03 Estimate, Sales $307.75M Beat $284.88M Estimate

For the full-year 2025, which will set the stage to become a pure-play Power company, we currently expect:
<ul>
<li>Consolidated revenue from continuing operations to grow mid-to-high single digit year-over-year as compared with equivalent revenue of $185.8 million in 2024.</li>
<li>Consolidated gross profit margin from continuing operations between 19.5% to 21.5%, reflecting the fact that we have completed the wind down of Transitional Foundry Services and new generation power products will just begin production in the second half 2025. The equivalent gross profit margin was 21.5% in 2024.</li>
</ul>

Magnachip Expects FY25 Revenue Growth From Continuing Operations Of Mid-To-High Single Digit Vs $185.8M YoY

Press Releases

AGAPE ATP Corporation Announces 1-for-20 Reverse Stock Split Effective August 30

AGAPE ATP Corporation Addresses Recent Corporate Exercise and Strategic Developments

ATPC Partners with Photons Solar to Advance Solar PV Mounting Systems in ASEAN

Agape ATP Corporation Regains Compliance with Nasdaq's Minimum Bid Price Rule

Agape ATP Launches ATP2, the Future of Health for Ultimate Vitality and Wellness

ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device

Agape ATP Corporation - Synergising Innovation Across Business Pillars to Make the World a Better Place

ATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia

Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. … more inside

Agape ATP Corporation Announces Key USD23.0 Million Private Placement to Institutional Investors

Comments

Agape ATP

Noticias

Últimas noticias sobre Agape ATP (NASDAQ:ATPC) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL